Ri Xi Lai

CXVCG's fund investment objective seeks superior returns. Their fund investment strategy targets firms operating primarily in biotechnology/life sciences (pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology) and high technology (energy, electronics, optoelectronics, communications, information technology and software). They provide financing for early and expansion stage capital requirements. Investment criteria they look for include firms with a strong proprietary position, breakthrough technology responding to a large potential market, and managed by experienced entrepreneurs. They also encourage synergies of technologies or products between their portfolio firms. CXVCG looks for firms in the Asia Pacific region as well as in North America. They are active, involved investment partners. In addition to providing capital, they support their portfolio firms with the development of corporate strategy, building strategic alliances and recruitment of top management.